| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 0.8 | 13.0 | 4.3 |
| Other income | 0.0 | 5.5 | 0.1 |
| Total income | 0.8 | 18.5 | 4.4 |
| Profit before exceptional items & tax | 0.2 | 2.2 | 0.4 |
| Profit before tax | 0.2 | 2.2 | 0.4 |
| Net profit | 0.1 | 1.7 | 0.4 |
| Operating margin | 25.0% | 11.9% | 9.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -75.00% |
|---|---|
| Net profit, quarter on quarter | -94.10% |
| Revenue, year on year | -81.40% |
| Operating profit, year on year | -33.30% |
| Operating profit, quarter on quarter | +106.10% |
BSE results filing, NSE: SRDAPRT. Figures extracted from the filing.
Fresita Proteins Ltd: key numbers
- Share price
- ₹125.05
- Market cap
- ₹112.2 Cr
- Revenue (annual)
- ₹16.16 Cr
- Net profit (annual)
- ₹0.64 Cr
- P/E (TTM)
- 40.2×Sector 38.6×
- Promoter holding
- 80.47%-0.19% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fresita Proteins Ltd
All →Fresita Proteins Capital Structure Change
Fresita Proteins fixed a Rs. 89.76 Crore rights issue at Rs. 120 per share, record date October 30, 2026. Issue closes November 26, 2026.
- Value
- ₹89.76 Cr
Fresita Proteins Board Meeting Date
Fresita Proteins intimated a Rights Issue Committee meeting on October 26, 2026, to finalize its ₹90 Crore rights issue terms. No decisions have been made yet.
Fresita Proteins Annual General Meeting
Fresita Proteins Limited concluded its 35th Annual General Meeting on September 30, 2026. Shareholders transacted five resolutions, including approval for borrowing and investment limits of ₹1,000 Crore each.
Sarda Proteins Price Movement Clarification
Sarda Proteins Limited responded to a BSE query regarding recent stock price movement. The company stated the fluctuations are driven by market forces and conditions.
Sarda Proteins Other Announcement
Sarda Proteins Limited has changed its name to Fresita Proteins Limited, effective September 21, 2026. The name change received approval from the Ministry of Corporate Affairs and BSE.
Sarda Proteins Annual Report
Sarda Proteins Limited filed its 35th Annual Report for the financial year ended 31st March 2026 with the stock exchange.